Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 19,428 shares at $75.15 ($1.5M) on 2024-06-28, disclosed to the SEC on 2024-07-02.
Scheduled sale ($1.5M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.15 | 7,565 | $569K | 38.8% |
| 2 | $75.15 | 7,565 | $569K | 38.8% |
| 3 | $76.19 | 1,863 | $142K | 9.7% |
| 4 | $76.19 | 1,863 | $142K | 9.7% |
| 5 | $76.73 | 572 | $44K | 3.0% |
| Total | $75.40 avg | 19,428 |
| $1.5M |
| 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |